There is currently a substantial translational effort to develop therapeutic strategies for AGS,28,29,30 and elucidation of the spatial dynamics of disordered IFN signaling within the brain will inform the development of optimal therapeutic strategies and clinical trial design.28 The gene discussed is IFNA1; the disease is Aicardi-Goutieres syndrome.